ATG5 and Hepatic fibrosis: In particular, atg5 deletion (Lodder et al, 2015; Habib et al, 2019) and genetic inhibition of LAP components (Wan et al, 2020) in the myeloid compartment exacerbate hepatic inflammation in mice with chronic liver injury, thus enhancing liver fibrosis.